Interim Efficacy and Safety Results from the Phase 3 ENDEAR Study of Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA)

التفاصيل البيبلوغرافية
العنوان: Interim Efficacy and Safety Results from the Phase 3 ENDEAR Study of Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA)
المؤلفون: Eugene Schneider, C.F. Bennett, Eugenio Mercuri, Nancy L. Kuntz, Wildon Farwell, Basil T. Darras, Jacqueline Montes, Z.J. Zhong, Haluk Topaloglu, John Su, Sarah Gheuens, Claudia A. Chiriboga, Francesco Muntoni, Richard S. Finkel
المصدر: Neuropediatrics. 48:S1-S45
بيانات النشر: Georg Thieme Verlag KG, 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, Pediatrics, medicine.medical_specialty, business.industry, General Medicine, Spinal muscular atrophy, medicine.disease, SMA, 03 medical and health sciences, 030104 developmental biology, Interim, Pediatrics, Perinatology and Child Health, medicine, Nusinersen, Neurology (clinical), business
تدمد: 1439-1899
0174-304X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5d1a711ca30feaf6ad0e80166da43e6bTest
https://doi.org/10.1055/s-0037-1602912Test
رقم الانضمام: edsair.doi...........5d1a711ca30feaf6ad0e80166da43e6b
قاعدة البيانات: OpenAIRE